131 related articles for article (PubMed ID: 354780)
1. Dietary lipid-dependent activation of the carcinogen N-2-fluorenylacetamide in rats as monitored by Salmonella typhimurium.
Castro CE; Felkner IC; Yang SP
Cancer Res; 1978 Sep; 38(9):2836-41. PubMed ID: 354780
[No Abstract] [Full Text] [Related]
2. Alteration of the ability of liver microsomes to activate N-2-fluorenylacetamide to a mutagen of Salmonella typhimurium during hepatocarcinogenesis.
Stout DL; Becker FF
Cancer Res; 1978 Aug; 38(8):2274-8. PubMed ID: 208764
[No Abstract] [Full Text] [Related]
3. In vitro metabolism and mutagenic activation of 2-acetylaminofluorene by subcellular liver fractions from Cotton rats.
Schut HA; Thorgeirsson SS
Cancer Res; 1978 Aug; 38(8):2501-7. PubMed ID: 352509
[No Abstract] [Full Text] [Related]
4. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide.
Hinson JA; Andrews LS; Gillette JR
Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868
[No Abstract] [Full Text] [Related]
5. The relationship of 2-acetamidofluorene mutagenicity in plate tests with its in vivo liver cell component distribution and its carcinogenic potential.
McGregor D
Mutat Res; 1975 Dec; 30(3):305-15. PubMed ID: 1105163
[TBL] [Abstract][Full Text] [Related]
6. Metabolic activation of 2-aminofluorene, 2-acetylaminofluorene and N-hydroxy-acetylaminofluorene to bacterial mutagens with mussel (Mytilus galloprovincialis) and carp (Cyprinus carpio) subcellular preparations.
Kurelec B; Krca S
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 88(1):171-7. PubMed ID: 2890481
[TBL] [Abstract][Full Text] [Related]
7. N'-hydroxy-2-aminofluorene: the principal mutagen produced from N-hydroxy-2-acetylaminofluorene by a mammalian supernatant enzyme preparation.
Stout DL; Baptist JN; Matney TS; Shaw CR
Cancer Lett; 1976 May; 1(5):269-74. PubMed ID: 797443
[TBL] [Abstract][Full Text] [Related]
8. Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium.
Weeks CE; Allaben WT; Louie SC; Lazear EJ; King CM
Cancer Res; 1978 Mar; 38(3):613-8. PubMed ID: 203386
[No Abstract] [Full Text] [Related]
9. Metabolism and mutagenic activation of 2-acetylaminofluorene by human liver and lung.
Boobis AR; Brodie MJ; McManus ME; Staiano N; Thorgeirsson SS; Davies DS
Adv Exp Med Biol; 1981; 136 Pt B():1193-201. PubMed ID: 7046385
[No Abstract] [Full Text] [Related]
10. Inhibitory effects of selenium of the mutagenicity of 2-acetylaminofluorene (AAF) and AAF derivatives.
Jacobs MM; Matney TS; Griffin AC
Cancer Lett; 1977 May; 2(6):319-22. PubMed ID: 324608
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of 2-fluorenamine-induced mutagenesis in Salmonella typhimurium by vitamin A.
Baird MB; Birnbaum LS
J Natl Cancer Inst; 1979 Oct; 63(4):1093-6. PubMed ID: 384006
[TBL] [Abstract][Full Text] [Related]
12. Effect of the structural isomer N-3-fluorenylacetamide on microsomal binding and hydroxylation of the carcinogen N-2-fluorenylacetamide.
Chow YM; Gutmann HR; Kaplan E
Biochem Pharmacol; 1981 Jun; 30(11):1253-61. PubMed ID: 7271824
[No Abstract] [Full Text] [Related]
13. Activation of 2-acetylaminofluorene in the nuclei of rat liver.
Kawajiri K; Yonekawa H; Hara E; Tagashira Y
Cancer Res; 1979 Mar; 39(3):1089-93. PubMed ID: 427750
[No Abstract] [Full Text] [Related]
14. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes.
Razzouk C; Batardy-Grégoire M; Roberfroid M
Cancer Res; 1982 Nov; 42(11):4712-8. PubMed ID: 7127306
[TBL] [Abstract][Full Text] [Related]
15. Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene.
Beranek DT; White GL; Heflich RH; Beland FA
Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5175-8. PubMed ID: 6752940
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of in vitro mutagenic activation and covalent binding of N-hydroxy-2-acetylaminofluorene in isolated liver cell nuclei from rat and mouse.
Sakai S; Reinhold CE; Wirth PJ; Thorgeirsson SS
Cancer Res; 1978 Jul; 38(7):2058-67. PubMed ID: 26463
[No Abstract] [Full Text] [Related]
17. Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538.
Weeks CE; Allaben WT; Tresp NM; Louie SC; Lazear EJ; King CM
Cancer Res; 1980 Apr; 40(4):1204-11. PubMed ID: 6986982
[No Abstract] [Full Text] [Related]
18. Use of the Ames test in assessing the relation of dietary lipid and antioxidants to N-2-fluorenylacetamide activation.
Black HS; Gerguis J
J Environ Pathol Toxicol; 1980 Aug; 4(1):131-8. PubMed ID: 7441107
[TBL] [Abstract][Full Text] [Related]
19. Subnanogram estimation of the proximate carcinogen N-hydryxy-2-fluorenylacetamide by gas-liquid chromatography.
Razzouk C; Lhoest G; Roberfroid M; Mercier M
Anal Biochem; 1977 Nov; 83(1):194-203. PubMed ID: 920936
[No Abstract] [Full Text] [Related]
20. Metabolic activation of 2-acetylaminofluorene.
Thorgeirsson SS; Wirth PJ; Staiano N; Smith CL
Adv Exp Med Biol; 1981; 136 Pt B():897-919. PubMed ID: 7046390
[No Abstract] [Full Text] [Related]
[Next] [New Search]
